B cell lymphoma with lung involvement: what is it about?

Area of Science:

• Hematology
• Oncology
• Pulmonology

Background:

• Primary lymphoma of the lung or pleura is exceptionally rare.
• Current data on the incidence of lung/pleural involvement in various B cell lymphomas is outdated.
• Understanding the frequency of primary and secondary lung/pleural lymphoma is crucial for accurate diagnosis and treatment.

Purpose of the Study:

• To determine the occurrence of primary and secondary lung and/or pleural involvement in B cell lymphomas in Austria.
• To identify which B cell lymphoma subtypes are most commonly associated with lung/pleural disease.
• To characterize the prevalence of primary lung/pleural lymphoma as a distinct entity.

Main Methods:

• Retrospective analysis of the Tyrolean registry for B cell non-Hodgkin's lymphomas.
• Screening of 854 patients diagnosed with B cell lymphoma.
• Categorization of lung/pleural involvement as primary or secondary.

Main Results:

• 7.5% of B cell lymphoma patients exhibited lung/pleural disease.
• Primary lung/pleural lymphoma occurred in only 0.7% of cases, while secondary involvement was found in 6.8%.
• Diffuse large B cell lymphoma (DLBCL) was the most common subtype with lung/pleural involvement (8%), followed by mucosa-associated tissue lymphoma (27%) and posttransplant lymphoproliferative disease (25%).

Conclusions:

• Lung and pleural involvement is a rare manifestation of B cell lymphomas, predominantly occurring as secondary disease.
• Diffuse large B cell lymphoma is the most frequently implicated subtype in secondary lung/pleural involvement.
• Primary lung/pleural lymphoma is an exceedingly rare neoplasm, accounting for a small fraction of lung cancers.